During the past decade, Arnhems Radiotherapeutisch Instituut conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arnhems Radiotherapeutisch Instituut" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials, followed by "Radboud University Medical Center" with 3 trials sponsored, "University Medical Center Groningen" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arnhems Radiotherapeutisch Instituut" #1 collaborator was "Dutch Cancer Society" with 5 trials as a collaborator, "Maastro Clinic, The Netherlands" with 2 trials as a collaborator, "Radiotherapiegroep" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Arnhems Radiotherapeutisch Instituut" are "Lung Cancer" (5 trials), "Breast Cancer" (4 trials), "Prostate Cancer" (3 trials), "Anal Cancer" (1 trials) and "Brain and Central Nervous System Tumors" (1 trials). Many other conditions were trialed in "Arnhems Radiotherapeutisch Instituut" in a lesser frequency.

Most popular intervention types in "Arnhems Radiotherapeutisch Instituut" are "Radiation" (15 trials), "Drug" (7 trials), "Procedure" (6 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (10 trials), "cisplatin" (4 trials), "adjuvant therapy" (3 trials), "conventional surgery" (2 trials) and "gemcitabine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arnhems Radiotherapeutisch Instituut" are 13 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Arnhems Radiotherapeutisch Instituut". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Arnhems Radiotherapeutisch Instituut, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Arnhems Radiotherapeutisch Instituut, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".